Medical technologies provider Teleflex has entered into a definitive agreement to acquire medical device company Vascular Solutions for $1bn.

Under the agreement, Teleflex will acquire all the issued and outstanding shares of Vascular Solutions common stock priced at $56.00 per share, in a cash-based transaction.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Subject to approval of Vascular Solutions’ shareholders and fulfillment of customary closing conditions, the potential transaction is expected to close during the first half of next year.

"Subject to approval of Vascular Solutions’ shareholders and fulfillment of customary closing conditions, the potential transaction is expected to close during the first half of next year."

Vascular Solutions primarily develops clinical solutions for minimally invasive coronary and peripheral vascular procedures and its product portfolio features more than 90 proprietary products and services for complex interventions, radial artery catheterizations and embolisation procedures.

Teleflex chairman and CEO Benson Smith said: “Vascular Solutions is a truly unique company with differentiated technologies serving the coronary and peripheral vascular markets.

“They have established a strong franchise focused on interventional cardiology and interventional radiology which complements Teleflex’s existing businesses.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

“Importantly, while we believe Vascular Solutions has compelling growth opportunities as they continue to build their business with their existing product portfolio, we look forward to potential longer-term tailwinds as we benefit from their robust R&D pipeline and our international distribution network moving forward.”

The transaction is expected to boost growth of Teleflex’s vascular and interventional businesses through increased revenue resulted with entry into the coronary and peripheral vascular market, as well as increasing customer bases for the increased cross-portfolio.

Teleflex has secured a new $750m senior unsecured bridge facility from JPMorgan Chase Bank to support the transaction.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact